JMI Syringes & Medical Devices Limited (DSE: JMISMDL)
Bangladesh
· Delayed Price · Currency is BDT 157.20
+2.30 (1.48%)
At close: Sep 12, 2024
JMISMDL Cash Flow Statement
Financials in millions BDT. Fiscal year is July - June.
Millions BDT. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '24 Mar 31, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | Jun '19 Jun 30, 2019 | 2018 - 2014 |
| Net Income | -167.37 | -149.96 | 100.6 | 89.11 | 96.04 | 66.55 | Upgrade
|
| Depreciation & Amortization | 73.97 | 76.92 | 76.58 | 75.24 | 64.55 | 55.02 | Upgrade
|
| Other Operating Activities | 8.68 | 13.83 | 7.47 | 2.25 | 2.32 | 161.45 | Upgrade
|
| Change in Accounts Receivable | 263.46 | 24.47 | 75.33 | 193.44 | -376.92 | -45.33 | Upgrade
|
| Change in Inventory | 191.51 | -113.1 | -182.32 | -76.53 | 24.8 | 2.26 | Upgrade
|
| Change in Accounts Payable | -357.33 | -188.72 | 308.3 | -66.02 | 126.08 | 116.91 | Upgrade
|
| Change in Income Taxes | 235.71 | 205.99 | -163.03 | -105.56 | -39.27 | 32.14 | Upgrade
|
| Change in Other Net Operating Assets | -48.53 | 196.29 | -182.14 | 73.17 | 69.66 | 11.15 | Upgrade
|
| Operating Cash Flow | 200.09 | 65.72 | 40.78 | 185.1 | -32.73 | 400.16 | Upgrade
|
| Operating Cash Flow Growth | 236.67% | 61.15% | -77.97% | - | - | 166.74% | Upgrade
|
| Capital Expenditures | -10.14 | -44.44 | -97.86 | -60.3 | -247.17 | -45.02 | Upgrade
|
| Sale of Property, Plant & Equipment | 1.13 | - | 0.05 | 0.53 | 1.17 | 11.73 | Upgrade
|
| Investing Cash Flow | -9.01 | -44.44 | -97.81 | -59.77 | -246 | -33.29 | Upgrade
|
| Short-Term Debt Issued | - | - | 160.08 | - | 52.53 | - | Upgrade
|
| Total Debt Issued | - | - | 160.08 | - | 52.53 | - | Upgrade
|
| Short-Term Debt Repaid | - | -82.02 | - | -76.8 | - | -533.94 | Upgrade
|
| Long-Term Debt Repaid | - | -0.84 | -5.37 | -4.86 | -34.48 | -1,141 | Upgrade
|
| Total Debt Repaid | -145.09 | -82.86 | -5.37 | -81.66 | -34.48 | -1,675 | Upgrade
|
| Net Debt Issued (Repaid) | -145.09 | -82.86 | 154.71 | -81.66 | 18.06 | -1,675 | Upgrade
|
| Issuance of Common Stock | - | - | - | - | - | 1,819 | Upgrade
|
| Common Dividends Paid | -29.97 | -0.24 | -68.76 | -65.65 | -66.53 | -27.85 | Upgrade
|
| Other Financing Activities | -8.62 | 21.8 | 17.02 | 39.22 | 16.98 | -154.78 | Upgrade
|
| Financing Cash Flow | -183.68 | -61.3 | 102.97 | -108.09 | -31.5 | -38.56 | Upgrade
|
| Net Cash Flow | 7.4 | -40.01 | 45.94 | 17.24 | -310.23 | 328.31 | Upgrade
|
| Free Cash Flow | 189.95 | 21.29 | -57.08 | 124.8 | -279.9 | 355.14 | Upgrade
|
| Free Cash Flow Growth | 2461.02% | - | - | - | - | 379.00% | Upgrade
|
| Free Cash Flow Margin | 11.05% | 1.21% | -2.34% | 6.26% | -14.16% | 19.97% | Upgrade
|
| Free Cash Flow Per Share | 6.32 | 0.71 | -1.90 | 4.15 | -9.31 | 11.82 | Upgrade
|
| Cash Interest Paid | 8.57 | 13.18 | 16.18 | 11.51 | 5.31 | 197.93 | Upgrade
|
| Cash Income Tax Paid | 80.55 | 110.27 | 163.03 | 105.56 | 87.2 | 101 | Upgrade
|
| Levered Free Cash Flow | 388.44 | 230.16 | -9.98 | 192.98 | -230.47 | 268.75 | Upgrade
|
| Unlevered Free Cash Flow | 391.59 | 238.24 | -1.74 | 199.96 | -227.37 | 379.82 | Upgrade
|
| Change in Net Working Capital | -284.92 | -161.23 | 113.17 | -69.11 | 174.1 | -165.33 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.